Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Jones

Showing results (231-240 of 333) with videos related to

Pageof 34
Sort By:
Cancers|November 30, 2019
Hypoxic Environment and Paired Hierarchical 3D and 2D Models of Pediatric <i>H3.3</i>-Mutated Gliomas Recreate the Patient Tumor ComplexityAnne-Florence Blandin, Aurélie Durand, Marie Litzler, et al.
Molecular Neurobiology|March 10, 2016
Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian PopulationSaoussen Trabelsi, Imen Chabchoub, Iadh Ksira, et al.
Acta Neuropathologica Communications|January 15, 2025
An exceptionally rare case of a diffuse midline glioma with concomitant H3.1 K27M and G34R mutations in the HIST1H3C (H3C3) geneZita Reisz, Rita Pereira, Smitha Nevis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomasJorge Sergio Reis-Filho, Pete T Simpson, Nicholas C Turner, et al.
Acta Neuropathologica|September 25, 2015
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypesDavid Castel, Cathy Philippe, Raphaël Calmon, et al.
Current Protocols|November 28, 2022
Quality Control Procedures for Genome-Wide Association StudiesVan Q Truong, Jakob A Woerner, Tess A Cherlin, et al.
The Journal of Pathology|March 11, 2020
The T-box transcription factor brachyury behaves as a tumor suppressor in gliomasFilipe Pinto, Ângela M Costa, Gisele C Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Targeted therapy for BRAFV600E malignant astrocytomaTheodore P Nicolaides, Huifang Li, David A Solomon, et al.
Plos One|March 6, 2012
Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomasStephanie Puget, Cathy Philippe, Dorine A Bax, et al.
Oncotarget|September 2, 2016
Characterizing and targeting PDGFRA alterations in pediatric high-grade gliomaCarl Koschmann, Daniel Zamler, Alan MacKay, et al.
Pageof 34

Showing results (231-240 of 333) with videos related to

Sort By:
Pageof 34
Cancers|November 30, 2019
Hypoxic Environment and Paired Hierarchical 3D and 2D Models of Pediatric <i>H3.3</i>-Mutated Gliomas Recreate the Patient Tumor ComplexityAnne-Florence Blandin, Aurélie Durand, Marie Litzler, et al.
Molecular Neurobiology|March 10, 2016
Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian PopulationSaoussen Trabelsi, Imen Chabchoub, Iadh Ksira, et al.
Acta Neuropathologica Communications|January 15, 2025
An exceptionally rare case of a diffuse midline glioma with concomitant H3.1 K27M and G34R mutations in the HIST1H3C (H3C3) geneZita Reisz, Rita Pereira, Smitha Nevis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomasJorge Sergio Reis-Filho, Pete T Simpson, Nicholas C Turner, et al.
Acta Neuropathologica|September 25, 2015
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypesDavid Castel, Cathy Philippe, Raphaël Calmon, et al.
Current Protocols|November 28, 2022
Quality Control Procedures for Genome-Wide Association StudiesVan Q Truong, Jakob A Woerner, Tess A Cherlin, et al.
The Journal of Pathology|March 11, 2020
The T-box transcription factor brachyury behaves as a tumor suppressor in gliomasFilipe Pinto, Ângela M Costa, Gisele C Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Targeted therapy for BRAFV600E malignant astrocytomaTheodore P Nicolaides, Huifang Li, David A Solomon, et al.
Plos One|March 6, 2012
Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomasStephanie Puget, Cathy Philippe, Dorine A Bax, et al.
Oncotarget|September 2, 2016
Characterizing and targeting PDGFRA alterations in pediatric high-grade gliomaCarl Koschmann, Daniel Zamler, Alan MacKay, et al.
Pageof 34